Quick Answer
Insight Molecular Diagnostics Inc. reported Research And Development Expense of $15.90 million for the year ending 2025.
- Insight Molecular Diagnostics Inc. showed an increase of +61.6% in Research And Development Expense from 2024 to 2025.
- This data is from Insight Molecular Diagnostics Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), Insight Molecular Diagnostics Inc.'s Research And Development Expense has grown by 301.3%.
- Historical annual values: Fiscal year 2025: $15.90 million | Fiscal year 2024: $9.84 million | Fiscal year 2023: $9.29 million | Fiscal year 2022: $7.30 million | Fiscal year 2021: $5.04 million | Fiscal year 2020: $9.80 million | Fiscal year 2019: $6.79 million | Fiscal year 2018: $6.51 million | Fiscal year 2017: $7.17 million | Fiscal year 2016: $5.68 million | Fiscal year 2015: $4.53 million | Fiscal year 2014: $3.96 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: